Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.

By C. Alix‐Panabières, K. Pantel. Cancer Discovery, 2016

1,205 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/08f49379a208313a466694975813d32b58e20ba2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Olivier Elemento
2. Lewis C. Cantley
3. M. V. Vander Heiden
4. Craig B. Thompson

In Molecular Biology

1. B. Hopkins
2. Mark A. Rubin
3. Olivier Elemento
4. Lewis C. Cantley
5. Christopher Kemp
6. David M. Sabatini
7. M. V. Vander Heiden
8. J. Engelman

In Oncology

1. Olivier Elemento
2. Lewis C. Cantley
3. Christopher Kemp

Citations in the corpus

• Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine (2017, background): “As previously published for breast, lung, and colorectal cancers, we also consider the ex vivo culture of circulating tumor cells to be a powerful resource (36, 37).”
• Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments (2022, background): “These analyses, therefore, aid in providing a detailed picture of tumor staging/subtypes and in designing novel personalized therapeutic drugs against tumors [62].”